Acurian Shortens Enrollment Time by over Five Months for a Pediatric Asthma Study

Respiratory

Pediatric Asthma

A sponsor was in a tight race to market when it initiated a phase III, two-protocol clinical trial designed to evaluate the efficacy and safety of its inhaler-delivered drug in pediatric patients with persistent asthma.

Read More »